This sheet is about exposure to a protein subunit COVID-19 vaccine in pregnancy and while breastfeeding. This information is based on published research studies. It should not take the place of medical care and advice from your healthcare provider. What is COVID-19? COVID-19 (Coronavirus Disease 2019) is an illness caused by a virus called SARS-CoV-2. The virus spreads mostly by close person-to-person contact. When an infected person breathes, talks, coughs, or sneezes, the virus can spread to …
Search Results for: covid
Fact Sheet: Remdesivir (Veklury®)
This sheet is about exposure to remdesivir in pregnancy and while breastfeeding. This information is based on available research studies. It should not take the place of medical care and advice from your healthcare provider. What is remdesivir? Remdesivir is an antiviral medication that has been approved to treat SARS-CoV-2 virus, which causes COVID-19. It has also been used to treat Ebola virus infections. Remdesivir is sold under the brand name Veklury®. Having a COVID-19 infection during …
Fact Sheet: Nirmatrelvir/Ritonavir (Paxlovid®)
This sheet is about exposure to nirmatrelvir/ritonavir in pregnancy and while breastfeeding. This information is based on published research studies. It should not take the place of medical care and advice from your healthcare providers. What is nirmatrelvir/ritonavir? Nirmatrelvir and ritonavir are medications that have been used together to treat COVID-19 (the illness caused by the SARS-CoV-2 virus). The combination of nirmatrelvir and ritonavir is sold under the brand name Paxlovid®. To …
Fact Sheet: Molnupiravir
This sheet is about exposure to molnupiravir in pregnancy and while breastfeeding. This information is based on available published literature. It should not take the place of medical care and advice from your healthcare provider. What is molnupiravir? Molnupiravir is an antiviral medication that has been given emergency permission by the U.S. Food and Drug Administration (FDA) to treat mild to moderate COVID-19 in certain patients. Molnupiravir must be started within 5 days of having symptoms …
Fact Sheet: Tofacitinib (Xeljanz®, Xeljanz XR®)
This sheet is about exposure to tofacitinib in pregnancy and while breastfeeding. This information is based on published research studies. It should not take the place of medical care and advice from your healthcare provider. What is tofacitinib? Tofacitinib is a medication that has been used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and ulcerative colitis. Some brand names for tofacitinib are Xeljanz® and Xeljanz XR®. MotherToBaby has fact sheets on …
